Treatment of diabetes with thiazolidinedione and sulphonylurea
AssigneeSmithKline Beecham Corporation
InventorsRobin Edwin Buckingham, Stephen Alistair Smith
Life of this patent
Estimating the term…
Abstract
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a sub-maximal amount of an insulin secretagogue, to a mammal in need thereof; and a pharmaceutical composition for use in such method.
Claims21
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a sub-maximal amount of an insulin secretagogue, to a mammal in need thereof.
A pharmaceutical composition comprising an insulin sensitiser, a sub-maximal amount of an insulin secretagogue and a pharmaceutically acceptable carrier therefor.
A pharmaceutical composition comprising an insulin sensitiser, a sub-maximal amount of an insulin secretagogue and a pharmaceutically acceptable carrier therefor, for use as an active therapeutic substance.
A pharmaceutical composition comprising an insulin sensitiser, a sub-maximal amount of an insulin secretagogue and a pharmaceutically acceptable carrier therefor, for use in the treatment of diabetes mellitus and conditions associated with diabetes mellitus.
Dependencies are inferred from the claim text.